PLPPR5-AS1: A Potential Drug Target and Biomarker (G100129620)

Target Name: PLPPR5-AS1

NCBI ID: G100129620

PLPPR5-AS1

Other Name(s): PLPPR5 antisense RNA 1

PLPPR5-AS1: A Potential Drug Target and Biomarker

PlGFP-AS1 (Platelet-derived growth factor-AS1) is a protein that is expressed in various tissues of the body, including platelets, endothelial cells, and fetal tissues. It is a potent regulator of cell proliferation and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

PLPPR5-AS1 functions as a negative regulator of the TGF-尾 pathway, which is a well-established regulator of cell growth and differentiation. The TGF-尾 pathway is involved in the development, maintenance, and repair of tissues, and is a target for many diseases, including cancer.

In cancer, the TGF-尾 pathway is often dysregulated, leading to the development of uncontrolled cell proliferation and the formation of tumors. PLPPR5-AS1 has been shown to play a role in regulating the TGF-尾 pathway in various contexts, including cancer.

Studies have shown that PLPPR5-AS1 is expressed in various types of cancer, including breast, ovarian, and colorectal cancers. In addition, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

PLPPR5-AS1 has also been shown to be involved in autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In these conditions, the immune system attacks the body's own tissues, leading to inflammation and damage.

Despite its potential as a drug target, PLPPR5-AS1 is still a relatively unexplored protein. There are currently no known drugs that specifically target PLPPR5-AS1. However, there is research being conducted to investigate the potential benefits and risks of targeting this protein in cancer and other diseases.

In conclusion, PLPPR5-AS1 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its regulation of the TGF-尾 pathway and its involvement in various diseases make it an attractive target for future research and development. Further studies are needed to fully understand the potential of PLPPR5-AS1 as a drug and to explore its potential as a biomarker.

Protein Name: PLPPR5 Antisense RNA 1

The "PLPPR5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLPPR5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.tech.

More Common Targets